公司资料
Bausch Health 股价、新闻与催化剂
- 股票代码:
- BHC
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- Canada and listed in the U
股票表现
6.58 USD (+1.08%)
收盘价
最后更新: 2026年8月17日
1.87B USD
市值
股价为何变动
As of Aug 17, 2026, BHC closed up 1.08% at $6.58. No new same-company headline was identified in the current news window.
公司概览
业务概览
Bausch Health is a diversified healthcare company with exposure to branded pharmaceuticals, specialty products, and medical aesthetics. Its business has been shaped by portfolio management, debt structure, and cash-flow durability.
所在地与行业分类
Bausch Health is headquartered in Canada and listed in the U.S. market. It sits in diversified healthcare and specialty pharma rather than pure biotech.
商业模式特征
The company depends on product sales, portfolio stabilization, and balance-sheet management. Investors focus on debt reduction, commercial execution, and the durability of its various franchises.
生物医药行业定位
Bausch Health sits outside biotech proper but remains highly relevant to healthcare investors. Its story is more about leverage, commercial execution, and portfolio value than about classic R&D catalysts.
未来催化剂
- Bausch Health’s catalysts are debt reduction, portfolio execution, and any update that clarifies the company’s path back to a cleaner earnings profile. The stock will care most about balance-sheet progress.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。